Taking Dantrium via Nose More Effective than by Mouth, Lowers Dose, Study Suggests

Taking Dantrium via Nose More Effective than by Mouth, Lowers Dose, Study Suggests
Giving Dantrium (dantrolene) through the nose rather than by mouth may maximize its neuroprotective properties in treating conditions like Alzheimer's disease, a new study suggests. The study, “Intranasal administration of dantrolene increased brain concentration and duration,” was published in the journal Plos One. Dantrium, produced by Par Sterile Products, is approved by the U.S. Food and Drug Administration (FDA) for treating chronic spasticity, or muscle spasms, from upper motor neuron disorders caused by multiple sclerosis and other conditions.
Subscribe or to access all post and page content.